1H,1H,2H,2H-Perfluorooctyltrimethoxysilane, 98.00%, 1g

4-Ethyl-4-methylpiperidine-2,6-dione, 95.0%, 250mg

(R)-1-Morpholinopropan-2-ol, 98%, 1g

Tert-butyl 6-((4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 98%, 250mg

N1-methyl-N1-(tetrahydro-2H-pyran-4-yl)benzene-1,4-diamine, 95%, 250mg

(S)-N-(1-Hydroxy-3-phenylpropan-2-yl)acetamide, 97.0%, 5g

(2R)-1-methanesulfonyl-2-methylpiperazine hydrochloride, 95.0%, 500mg

2-(Difluoromethyl)-6-methylpyridine, 97.0%, 1g

3-Bromo-5-nitrosalicylaldehyde>95.0%(GC)(T)5g

1-Methylguanidine hydrochloride, 95.0%, 100g

RuPhos Pd G3, >98.0%, 100mg

1-(2-Benzyloxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole, 98%, 1g

Metilciclohexano, mínimo 99%, para síntesis, 25 l, whitbl.